RE:RE:RE:RE:RE:RE:RE:Why is this dropping?virtually inaccessible..? are you nuts.. ? The treatment cost upfront may be high, but over the lifetime of a patient it comes in far cheaper for the payers - no more hospitalisations and no more agony for the sufferers. Sickle Cell also mostly affects African Americans amongst the US population - in this age of wokeness it's a therapy that will not be allowed to fail or not be offered, as it targets a mostly under-served popualtion group.
As for ONCY. whilst it's good to have confidence, some common sense is needed too - were you blind to the recent financing and other shenanigans taking place... when the recent financing was announced it was a clear signal they had no partner in sight. Then the PanCan trial was abruptly taken off the table.. Nothing from AN on Phase III... their BD director gone AWOL, and a change of address... there's an awful lot to be concerned about... Where is that Panc CR patient ? no longer a CR eh. What about Car-T use ? nothing in two years on that either...
So now you're underwater Azzak... You can be as arrogant and derogatory as you like, but for all your rainbows and unicorns, facts is. you're sat on a loss.
Whilst I can now buy back for half the cost I sold at. But hey, you're the smart one. lol